Patrick Kevin Kane - 30 Oct 2026 Form 3 Insider Report for INSMED Inc (INSM)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
03 Nov 2026, 16:14:03 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick Kane, by Michael A. Smith as Attorney-in-fact
Filing notes and source

Key filing fact

Patrick Kevin Kane filed Form 3 for INSMED Inc (INSM) on 03 Nov 2026.

Key facts

  • This page summarizes Patrick Kevin Kane's Form 3 filing for INSMED Inc (INSM).
  • 0 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 03 Nov 2026, 16:14.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002162177 Primary reporting owner

Kane Patrick Kevin

Relationship
Corporate Controller
Address
700 US HIGHWAY 202/206, BRIDGEWATER
Signature
/s/ Patrick Kane, by Michael A. Smith as Attorney-in-fact
Signature date
03 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,921
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,580
Exercise price
$177.12
Footnotes
F2
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,310
Exercise price
$67.22
Footnotes
F2
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,430
Exercise price
$65.72
Footnotes
F2
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,560
Exercise price
$25.83
Footnotes
F2
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,180
Exercise price
$29.13
Footnotes
F3
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,060
Exercise price
$18.95
Footnotes
F3
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,870
Exercise price
$19.74
Footnotes
F3
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,914
Exercise price
$17.07
INSM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
30 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
643
Exercise price
$26.43
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended, 2,258 of which vest 25% on each anniversary of the date of the grant through the fourth anniversary of the date of the grant and 5,246 of which vest 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

Footnote F2

These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Footnote F3

These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the date of grant and an additional 12.5% vest on each six-month anniversary of such date until fully vested.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .